China Medical GatewayLoading your healthcare gateway…

Tianjin First Central Hospital

Tianjin First Central Hospital — Tianjin

Hospital Profile

Tianjin First Central Hospital was established in 1942. It is a tertiary Grade A general hospital featuring organ transplantation, emergency medicine, and otolaryngology-head and neck surgery, and is a project under construction as Tianjin Medical Center and a national regional medical center. The hospital has 8 national key clinical specialties, 12 key medical disciplines in Tianjin, and 16 key clinical specialties in Tianjin. Its Organ Transplantation Center is a well-known domestic center, having performed over ten thousand liver transplants. The Department of Critical Care Medicine is one of the birthplaces of critical illness emergency treatment integrating traditional Chinese and Western medicine nationwide (Professor Wang Jinda developed the "dual treatment of infection and toxin" theory). The Department of Otolaryngology-Head and Neck Surgery established the Tianjin Institute of Otolaryngology. The hospital led and completed the world's first chemical reprogramming-induced pluripotent stem cell-derived islet transplantation for type 1 diabetes, which was published in Cell (selected as one of the "Top Ten Advances in Chinese Medical Biotechnology in 2024"). It has received multiple honors, including "Top 100 Hospitals in China" and "National Model Hospital Trusted by the People."

Medical Milestones

The hospital was established in 1942 (originally named Tianhe Hospital) and was renamed Tianjin First Central Hospital in 1956; in 1974, Professor Wang Jinda founded the Emergency Medicine Research Institute; in 1989, the Tianjin Institute of Otolaryngology was established; in 1998, the Organ Transplantation Center was founded; in 2017, it signed an agreement to become an affiliated hospital of Nankai University; it led the completion of the world's first chemical reprogramming-induced pluripotent stem cell-derived islet transplantation treatment for type 1 diabetes (results published in Cell, 2024).

Key Capabilities & Patient Care

There are 47 clinical specialty departments. It is qualified to perform various types of organ transplants, including heart, liver, kidney, pancreas, lung, and small intestine; it is at an advanced level in Tianjin in areas such as complex coronary heart disease intervention, large vessel and cerebrovascular intervention/surgery, and treatment of severe cranial trauma. It has established two-way referral systems with communities and serves as a mutual recognition institution for laboratory and imaging services in the Beijing-Tianjin-Hebei region; it has been accredited as a national Chest Pain Center and a Tianjin Stroke Center; it has launched an internet hospital with functions such as mobile healthcare and remote consultations, creating a new convenient medical service model through the "three-medical linkage" system; it has repeatedly undertaken the treatment of critically injured patients in major rescue and disaster situations.

Advanced Technology

There are currently 2 clinical campuses and 1 research and teaching campus (with the new main building having a single building area of 380,000 square meters). The institution has 5 provincial and ministerial key laboratories (including the Key Laboratory of Critical Care Medicine), 6 affiliated research institutes, and a clinical medicine postdoctoral workstation. It also houses the largest medical simulation teaching center in Tianjin and a national standardized residency training base. The facility is equipped with world-class medical equipment. Data Statistics: • Bed Capacity: Planned beds 3,200 (In 2023, the original campuses had more than 1,500 beds; the Organ Transplant Center had over 200 beds; the new site is set to have 2,000 beds) • Total Staff: Over 4,000 employees (2023) • Inpatients: Annual total not disclosed; in 2023, daily inpatient services served 2,390 cases (peak after Shui Xi opening); estimated annual discharges approximately 90,000–110,000 cases • Outpatient and Emergency Visits: Over 2 million annually; peak daily outpatient and emergency visits 8,600 (2023) • Inpatient and Elective Surgeries: Annual total not disclosed; estimated about 50,000–60,000 procedures/year • Number of Senior Title Physicians: Official total not disclosed; estimated about 480–640 (this is an estimate, not official data, based on 4,000 staff × 12%-16%)

International Patient Services

It has the Tianjin International Medical Treatment Center, providing medical services for foreign guests in Tianjin; it maintains long-term friendly cooperative exchanges with internationally renowned institutions such as Johns Hopkins University, Mayo Clinic, New York University School of Medicine, UCLA, and the University of Chicago; it was once designated as a hospital for the Tianjin competition area of the Beijing Olympic Games.

Return to Home